Bolsonaro criticizes the parliamentary committee on the epidemic in Brazil, saying that it “only talks about chloroquine”

Brazil has surpassed 420,000 deaths since the start of the epidemic

Madrid, May 9. (Europe Press) –

Brazil’s President, Jair Bolsonaro, criticized again on Saturday the parliamentary committee investigating the management of the coronavirus epidemic, saying that they “only talk about chloroquine”, which is used to fight COVID-19 in the country, despite the fact that the effectiveness has not been proven.

He said during a meeting with his followers, “The Parliamentary Investigation Committee is only talking about chloroquine, but those who oppose it did not find another alternative.” He said, “I’m sure someone took hydroxychloroquine here,” and some have responded positively.

Bolsonaro, who appeared again in public without a mask, argued that “the virus must be confronted” and lamented the deaths of people in the country due to COVID-19, according to the Brazilian newspaper ‘O Globo’.

“It is difficult for someone not to have a father who died of COVID-19 or of course COVID-19. Everything is suspected of being COVID-19,” he noted, a day after the International Criminal Court agreed to conduct an investigation. For federal government officials to use chloroquine to fight coronavirus.

Brazil is the country with the largest number of injuries and deaths in Latin America and the third in the world in terms of the number of injuries, with more than 15 million.

On Saturday, the Ministry of Health was notified of 2,202 new deaths from the disease, more than 420,000 deaths since the start of the epidemic, specifically 421,316 deaths.

With regard to infection, 63,430 new cases were registered in the last day, bringing the total number of cases to 15,145,879.

In the vaccination plan, about 35 million Brazilians have received at least one dose of the COVID-19 vaccine, and the Ministry of Health announced this Saturday that it has sent a shipment of 3.9 million doses of AstraZeneca vaccine nationwide.